Edition:
United States

Aptose Biosciences Inc (APTO.OQ)

APTO.OQ on NASDAQ Stock Exchange Capital Market

2.06USD
18 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.06
Open
$2.12
Day's High
$2.16
Day's Low
$2.06
Volume
42,039
Avg. Vol
28,401
52-wk High
$4.55
52-wk Low
$1.70

Chart for

About

Aptose Biosciences Inc. (Aptose) is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs that target specific epigenetic processes and signal transduction abnormalities that underlie a particular life-threatening malignancy. Its product pipeline includes cancer drug candidates... (more)

Overall

Beta: 1.86
Market Cap(Mil.): $82.38
Shares Outstanding(Mil.): 37.77
Dividend: --
Yield (%): --

Financials

  APTO.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -0.81 -- --
ROI: -218.27 0.60 13.80
ROE: -218.27 -2.18 15.29

Earnings vs. Estimates